PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2010 | 82 | 6 | 371-375
Tytuł artykułu

Biosurgery the Future of non Healing Wounds

Treść / Zawartość
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Słowa kluczowe
Wydawca
Rocznik
Tom
82
Numer
6
Strony
371-375
Opis fizyczny
Daty
wydano
2010-06-01
online
2010-09-15
Twórcy
  • Department of Dermatology and Venerology, Medical University of Silesia in Katowice
  • Department of Dermatology and Venerology, Medical University of Silesia in Katowice
  • Department of Dermatology and Venerology, Medical University of Silesia in Katowice
Bibliografia
  • Gwynne B, Newton M: An overview of the common methods of wound debridement. Br J Nurs 2006; 15: S4-S10.[PubMed]
  • Whitaker IS, Twine Ch, Whitaker MJ Et al.: Larval therapy from antiquity to the present day: mechanisms of action, clinical applications and future potential. Postgrad Med J 2007, 83: 409-13.[WoS][Crossref]
  • Sherman RA, Hall MJR, Thomas S: Medical Maggots: An Ancient Remedy for Some Contemporary Affilctions. Annu Rev Entomol 2000; 45: 55-81.[Crossref]
  • Orkiszewski M: Zastosowanie larw muchy Lucilia sericata w leczeniu trudno gojących się ran. Wiad Lek 2007; 60: 7-8.
  • Gupta A: A Review of the Use of Maggots in Wound Therapy. Ann Plast Surg 2008; 60: 224-227.[WoS][PubMed][Crossref]
  • Chan D, Fong D, Leung J et al.: Maggot debridement therapy in chronic wound care. Honk Kong Med J 2007; 13: 382-386
  • Steenvoorde P, Calame JJ, Oskam J: Maggot-treated wounds follow normal wound healing phases. Int J Dermatol 2006; 45: 1477-1479.[PubMed][Crossref]
  • Nigam Y, Bexfield A, Thomas S et al.: Maggot Therapy: The Science and Implication for CAM Part I-History and Bacterial Resistance. Evid Based Complement Alternat Med 2006; 3(2): 223-227.
  • Blake FAS, Abromeit N, Bubenheim M et al.: The biosurgical wound debridement: Experimental investigation of efficiency and practicability. Wound Repair Regen 2007; 15: 756-761.[Crossref][WoS]
  • Thomas S, Jones M, Shutler S et al.: Wound care: all you need to know about maggots. Nurs Times 1996; 92: 63-70.
  • Wollina U, Liebold K, Schmidt WD et al.: Biosurgery supports granulation and debridement in chronic wounds-clinical data and remittance spectroscopy measurement. Int J Dermatol 2002; 41: 635-39.[Crossref]
  • Cazander G, Veen KEB, Bernards AT et al.: Do maggots have an influence on bacterial growth? A study on the susceptibility of strains of six different bacterial species to maggots of Lucilia sericata and their excretions/secretions. J Tissue Viability 2009; 18: 80-87.
  • Bexfield A, Nigam Y, Thomas S et al.: Detection and partial characterization of two antibacterial factors from the excretions/secretions of the medical maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA). Microbes Infect 2004; 6: 1297-04.[Crossref]
  • Beasley WD, Hirst G: Making a meal of MRSA-the role of biosurgery in hospital-acquired infection. J Hosp Infect 2004; 56: 6-9.[PubMed][Crossref]
  • Bexfield A, Bond AE, Roberts EC et al.: The antibacterial activity against MRSA strains and other bacteria of a <500 Da fraction from maggot excretions/secretions of Lucilia sericata (Diptera: Calliphoridae). Microbes Infect 2008; 10: 325-33.[WoS]
  • Cazander G, Veen KEB, Bouwman LH et al.: The Influence of Maggot Excretions on PAO1 Biofilm Formation on Different Biomaterials. Clin Orthop Relat Res 2009; 467: 536-45.
  • Prete PE: Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci 1997; 8: 505-10.[Crossref]
  • Horobin AJ, Shakesheff KM, Pritchard DI: Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface. Wound Repair Regen 2005; 13: 422-33.[Crossref]
  • Nigam Y, Bexfield A, Thomas S et al.: Maggot Therapy: The Science and Implication for CAM Part II-Maggots Combat Infection. Evid Based Complement Alternat Med 2006; 3: 303-08.
  • Plas MJA, Does AM, Baldry M et al.: Maggot excretions/secretions inhibit multiple neutrophil pro-inflamatory responses. Microbes Infect 2007; 9: 507-514[WoS][Crossref]
  • Plas MJA, Baldry M, Dissel JT et al.: Maggot secretions suppress pro-inflamatory responses of human monocytes through elevation of cyclic AMP. Diabetologia 2009; 52: 1962-70.[WoS][Crossref]
  • Wang S, Wang K, Xin Y et al.: Maggot excretions/secretions induces human microvascular endothelial cell migration through AKT1. Mol Biol Rep 2009; Published online: 16 Sep.[WoS]
  • Sherman RA: Maggot Therapy for Treating Diabetic Foot Ulcers Unresponsive to Conventional Therapy. Diabetes Care 2003; 26: 446-51.[Crossref][PubMed]
  • Jukema GN, Menon AG, Bernards AT et al.: Amputation-Sparing Treatment by Nature: "Surgical" Maggots Revisited. Clin Infect Dis 2002; 35: 1566-71.[Crossref]
  • Sherman RA, Shimoda KJ: Presurgical Maggot Debridement od Soft Tissue Wounds Is Associated with Decreased Rates of Postoperative Infection. Clin Infect Dis 2004; 39: 1067-70.[Crossref]
  • Sherman RA: Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound Repair Regen 2002; 10: 208-14.[PubMed][Crossref]
  • Steenvoorde P, Jacobi CE, Doorn L et al.: Maggot debridement therapy of infected ulcers: patient and wound factors influencing outcome - a study on 101 patients with 117 wounds. Ann R Coll Surg Engl 2007; 89: 596-602.[WoS]
  • Mumcuoglu KY, Ingber A, Gilead L et al.: Maggot therapy for the treatment of intractable wounds. Int J Dermatol 1999; 38, 623-27[Crossref]
  • Sherman RA, Shapiro CE, Yang RM: Maggot Therapy for Problematic Wounds: Uncommon and Off-label Applications. Adv Skin Wound Care 2007; 20: 602-10.[PubMed]
  • Wollina U, Karte K, Herold C et al.: Biosurgery in wound healing - the renaissance of maggot therapy. J Eur Acad Dermatol Venereol 2000; 14: 285-89.[Crossref]
  • BioTherapeutics, Education and Research Foundation - Maggot Debridement Therapy: Draft Policy and Procedure.
  • Claxton MJ, Armstrong DG, Short B et al.: 5 Questions - and Answers - about Maggot Debridement Therapy. Adv Skin Wound Care 2003; 16: 99-102.
  • Steenvoorde P, Doorn LP: Maggot Debridement Therapy: Serious Bleeding Can Occur. J Wound Ostomy Continence Nurs 2008; 35: 412-14.[PubMed]
  • Waymen J, Nirojogi V, Walker A et al.: The cost effectiveness of larval therapy in venous ulcers. J Tissue Viability 2000; 10: 91-94. Erratum in: J Tissue Viability 2001; 11: 51.
  • Thomas S, Jones M: Wound debridement: evaluating the costs. Nurs Stand 2001; 15: 59-61.[PubMed]
  • Dumville JC, Worthy G, Bland M et al.: Larval therapy for leg ulcers (VenUS II): randomized controlled trial. BMJ 2009; 338:b773 doi: 10.1136/bmj.b773.[Crossref]
  • Sherman RA, Wyle RA: Low-cost, low-maintenance rearing of maggots in hospitals, clinics, and schools. Am J Trop Med Hyg 1996; 54: 38-41.[PubMed]
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.-psjd-doi-10_2478_v10035-010-0054-5
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.